Goldman Sachs remains upbeat over AI, health in 2024
Investors should pay attention to artificial intelligence (AI), software, health care and biotechnology in 2024 as these fields promise “more return dispersion across asset classes, sectors and regions, with complex choices and tradeoffs,” a Goldman Sachs Asset Management said, Monday.
Nov 27, 2023By Yi Whan-woo